Navigation Links
Decision Resources Group Acquires Relay Technology Management
Date:1/7/2014

BURLINGTON, Mass. and CAMBRIDGE, Mass., Jan. 7, 2014 /PRNewswire/ -- Piramal Enterprises' Information Management Subsidiary, Decision Resources Group, one of the world's leading research and advisory firms focusing on high-value healthcare insights and analytics, announced today that it acquired Relay Technology Management, a data analytics company focused on the life-sciences industry. The acquisition of Cambridge, Mass.-based Relay by Burlington, Mass.-based Decision Resources Group is a significant strategic step in Decision Resources Group's effort to supply its clients with premier data analytics through delivery systems that most fit their needs.

Jim Lang, CEO of Decision Resources Group said, "This important acquisition brings us three things, 1) exciting products for early stage pipeline analysis, drug target evaluation, and KOL identification, 2) a world class data and analytics leadership team, and 3) proprietary natural language processing technology, healthcare ontology, and scalable data and insight visualization platform to allow us to introduce new products and services much more quickly to our clients and to enhance our current high-value offerings."

Relay's concentration in the life-sciences industry means they are familiar with the various disparate databases and information sources that Decision Resources Group's pharmaceutical and medtech clients work with on a regular basis. They offer a way to organize and synthesize these data sets to service a multitude of organizational users.

"With Relay's ability to make sense of disparate structured and unstructured data, we can then layer on the 'so-what' insights from our premier analysts to add value to those data views – this will allow our clients to have a level of intelligence that is second-to-none in the industry," continued Mr. Lang.

"We look forward to applying our next-generation, interactive data analytics platform to Decision Resources Group's strong multidimensional offering known for top-level analysis and insight," said Brigham Hyde, CEO of Relay Technology Management. "Together, Decision Resources Group and Relay will deliver the type of data-driven solutions and predictive analytics that is critical to the current competitive environment of today's biopharma and device organizations."

Relay will move to Decision Resources Group's corporate office location in Burlington, Mass.

About Relay Technology Management
Relay Technology Management is a life sciences business intelligence and analytical software provider founded in 2008 with one core belief: that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will led to increased efficiency in drug and device development. Data-driven decision-making is the key to delivering novel, cost effective, and efficacious care to patients worldwide. For more information on Relay, please visit: www.relaytm.com

About Decision Resources Group
Decision Resources, Inc. is a world leader in high-value data, analytics and advisory services designed to help clients shape strategy, allocate resources and master their chosen markets. For more information, please visit www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or
registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall
Decision Resources Group
781-993-2563
emarshall@dresourcesgroup.com


'/>"/>
SOURCE Decision Resources Group
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Genomic Health Presents Results From First Clinical Decision Making Study of Oncotype DX® Colon Cancer at the 2012 Gastrointestinal Cancers Symposium
2. Sequenom Addresses Preliminary Injunction Decision, Reaffirms Defense of Patent
3. Laboratory Decision Makers Cautiously Optimistic about Funding Conditions, Finds Frost & Sullivan
4. Neural implant recovers ability to make decisions
5. QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies
6. Country and Site Selection: Optimizing Protocol Planning Decisions by Leveraging Data Through Custom Algorithms, New Webinar Hosted by Xtalks
7. Butamax Announces Immediate Appeal of Court Decisions on Claim Construction and Summary Judgment
8. Health Decisions CEO Michael Rosenberg Named a Business Leader Top Entrepreneur for 2013
9. Advancing Preclinical Predictions, Making Faster Clinical Decisions with Cancer Models and Preclinical Imaging - World Pharma Congress this June in Philadelphia
10. Computational Analysis in Clinical and Preclinical Decision-Making, new webinar hosted by Xtalks
11. ChemAxon Major Software Release brings New Desktop, Web and Visualization Applications to Power Chemistry Decision Making
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... and CARDIFF, UK (PRWEB) , ... June 23, 2017 , ... ... and Brian Lula, president of Physik Instrumente USA, have been selected as this year’s ... photonics . , The two have been invited along with other honorees to accept ...
(Date:6/22/2017)... ... 2017 , ... Beaker, the industry’s pioneer in developing customizable ... industry, today announces a strategic partnership with Alcami Corporation, a leading global Contract ... expertise in executive recruitment solutions, providing Alcami with access to the best talent ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... specialists DST Diagnostische Systeme & Technologien GmbH, thereby expanding its product portfolio to ... from hay fever, urticaria, asthma, atopic eczema or a food allergy. Allergies are ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... clients throughout the biopharma and life sciences industries, continue to be in demand ... Tunnell’s Kip Wolf will be speaking on “The State of Information Governance in ...
Breaking Biology Technology:
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
Breaking Biology News(10 mins):